4.8.13.4Vertical

Surgical Stapling & Closure

Stapling devices, sutures, and wound closure products.

Market snapshot

These figures describe Wound Care & General Surgery Devices (4.8.13), the segment that Surgical Stapling & Closure sits within. They are not figures for Surgical Stapling & Closure on its own.

Market size
~$38B
Growth
~2.6%CAGR (2017–22, nominal)
Companies
~1,608 firms
Firms by employee count

70.2% of firms have fewer than 20 employees: 1,129 micro-businesses, below most mandates.

The investable universe479 firms with 20+ employees
20–99
27357%
100–499
12125%
500+
8518%

~1,600 makers of advanced dressings, negative-pressure wound therapy, and surgical stapling and closure, led by Smith+Nephew, Solventum, Convatec, and Mölnlycke. Aging, diabetes, and chronic-wound prevalence drive steady ~2.6%/yr demand, with the advanced and biologic wound tier the higher-value, faster-growing slice. Asset-heavy: payroll is just 19% of revenue.

NAICS 339113. U.S. Census Bureau, 2022 Statistics of U.S. Businesses; U.S. Census Bureau, 2022 Economic Census.

Business model & economics

Revenue model

Device and recurring-consumable sales

Key economics

Revenue per firm
$23,586,588
Revenue per employee
$440,927
Employees per firm
59.7
Recurring revenue
High

recurring dressings and consumables

EBITDA margin
18–28%
Capex intensity
High

Characteristics

  • Scale-driven: payroll is only 19% of revenue, so the cost base is assets, not headcount
  • Moderate strategic-buyer pool: 85 firms exceed 500 employees, so a scaled asset has buyers, but not many
  • Aging, diabetes, and chronic-wound prevalence drive demand.
  • Advanced and biologic wound products the higher-value tier.
  • Devices plus recurring consumables.

NAICS 339113. U.S. Census Bureau, 2022 Statistics of U.S. Businesses; U.S. Census Bureau, 2022 Economic Census.

Geographic concentration

AlabamaAlaskaArizonaColoradoFloridaGeorgiaIndianaKansasMaineNew JerseyNorth CarolinaNorth DakotaOklahomaSouth DakotaTexasWyomingConnecticutMissouriWest VirginiaIllinoisNew MexicoArkansasCaliforniaDelawareDistrict of ColumbiaHawaiiIowaKentuckyMarylandMichiganMississippiMontanaNew HampshireNew YorkOregonTennesseeUtahVirginiaWashingtonWisconsinNebraskaSouth CarolinaIdahoNevadaVermontLouisianaRhode IslandMassachusettsMinnesotaPennsylvaniaOhio

Wound-care and general-surgery device manufacturing concentrates in Minnesota, Massachusetts, Ohio, and Pennsylvania, building on each state's medical-device manufacturing base.

MinnesotaMassachusettsOhioPennsylvania

U.S. Census Bureau, 2022 Statistics of U.S. Businesses (firms by state), NAICS 339113. Concentration shown by location quotient.

M&A deal context

Deal activityModerate

Who’s acquiring

  • Wound-care & surgery strategics
  • Diversified medtech platforms
  • PE-backed device companies

What’s driving deals

  • Acquisition of advanced and biologic wound products.
  • Chronic-wound prevalence demand.
  • Recurring-consumable economics.

Find Surgical Stapling & Closure acquisition targets

Search Acquisera’s index for companies classified under Surgical Stapling & Closure (4.8.13.4) and build a targeted deal pipeline.

Search companies